Type 2-diabetes - Sundhedsstyrelsen

240
The sixth report of the Joint National Committee on prevention, detection, evaluation,
and treatment of high blood pressure. Arch Intern Med 1997; 157(21):2413-2446.
241
Friedman GD, Selby JV, Quesenberry CP, Jr., Armstrong MA, Klatsky AL. Precursors of
essential hypertension: body weight, alcohol and salt use, and parental history of hypertension.
Prev Med 1988; 17(4):387-402.
242
National High Blood Pressure Education Program. Working Group Report on Primary
Prevention of Hypertension. NIH publ. no. 93-2669. U.S. Department of Health and Human
Services. 1993
243
Israelsson B. Role of alcohol, glucose intolerance and obesity in hypertriglyceridemia.
Atherosclerosis 1986; 62(2):123-127.
244
Pownall HJ, Ballantyne CM, Kimball KT, Simpson SL, Yeshurun D, Gotto AM, Jr. Effect
of moderate alcohol consumption on hypertriglyceridemia: a study in the fasting state.
Arch Intern Med 1999; 159(9):981-987.
245
Wei M, Gibbons LW, Mitchell TL, Kampert JB, Blair SN. Alcohol intake and incidence
of type 2 diabetes in men. Diabet Care 2000; 23(1):18-22.
246
Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH, Jr., Kostis JB et al.
Sodium reduction and weight loss in the treatment of hypertension in older persons:
a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE).
TONE Collaborative Research Group. JAMA 1998; 279(11):839-846.
247
Wylie-Rosett J, Wassertheil-Smoller S, Blaufox MD, Davis BR, Langford HG, Oberman A
et al. Trial of antihypertensive intervention and management: greater efficacy with
weight reduction than with a sodium-potassium intervention. J Am Diet Assoc 1993;
93(4):408-415.
248
Wassertheil-Smoller S, Blaufox MD, Oberman AS, Langford HG, Davis BR, Wylie-Rosett
J. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate
weight loss, alone and combined with drug therapy in the treatment of mild hypertension.
Arch Intern Med 1992; 152(1):131-136.
249
The effects of nonpharmacologic interventions on blood pressure of persons with high
normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA 1992;
267(9):1213-1220.
250
Kaplan NM. Evidence in favor of moderate dietary sodium reduction. Am J Hypertens
2000; 13(1 Pt 1):8-13.
354 TYPE 2-DIABETES – Medicinsk teknologivurdering af screening, diagnostik og behandling